Ammerpohl O, Trauzold A, Schniewind B, Griep U, Pilarsky C, Grutzmann R, Saeger HD, Janssen O, Sipos B, Kloppel G, Kalthoff H.
Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells.
Brit J Cancer 96: 73-81, 2007
Beetz S, Diekhoff D, Steiner LA.
Characterization of terminal deoxynucleotidyl transferase and polymerase mu in zebrafish.
Immunogenetics 59: 735-44, 2007
Beetz S, Marischen L, Kabelitz D, Wesch D.
Human gamma/delta-T cells: candidates for the development of immunotherapeutic strategies.
Immunol Res 37: 97-111, 2007
Bismarck v P, Klemm K, Wistädt CFG, Winoto-Morbach, S, Uhlig U, Schütze S, Uhlig S, Lachmann B, Krause MF.
Surfactant "fortification" by topical inhibition of nuclear factor-kB activity in a newborn piglet lavage model*.
Crit Care Med 35: 2309-2318, 2007
Feig C, Tchikov V, Schütze S, Peter ME.
Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signalling.
EMBO J 26: 221-231, 2007
Friedrich K, Janssen O, Hass R
Meeting report: tumor biology - how signaling processes translate to therapy
Sci STKE 381:13, 2007
Hinz S, Pagerols-Raluy L, Oberg HH, Ammerpohl A, Grüssel S, Sipos B, Grützmann R, Pilarsky C, Ungefroren H, Saeger HD, Klöppel G, Kabelitz D, Kalthoff H.
Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer.
Cancer Res 67: 8344-8350, 2007
Kabelitz D.
Expression and function of Toll-like receptors in T lymphocytes.
Curr Opin Immunol 19: 39-45, 2007
Kabelitz D, Medzhitov R.
Innate immunity - cross-talk with adaptive immunity throug pattern recognition receptors and cytokines.
Curr Opin Immunol 19: 1-3, 2007
Kabelitz D, Wesch D.
T-Zell-Rezeptor-Repertoire. In: Zelluläre Diagnostik. Grundlagen, Methoden und klinische Anwendungen der Durchflusszytometrie. Sack U, Tarnok A, Rothe G (Hrsg.)
Karger Publishers, Basel, 282-293, 2007
Kabelitz D, Wesch D, He W.
Perspectives of gamma/delta-T cells in tumor immunology.
Cancer Res 67: 5-8, 2007
Kling C, Wilke G, Schmutzler A, Hedderich J, Kabelitz D.
Verlauf 2 Jahre nach wiederholtem Implantationsversagen im IVF-Programm.
Geburtsh Frauenheilk 67: 1002-1008, 2007
Lamprecht P, Gross WL, Kabelitz D.
T cell alterations and lymphoid neogenesis favoring autoimmunity in Wegener´s granulomatosis.
Arthritis Rheum 56: 1725-1727, 2007
Lettau M, Beyer A, Janssen O.
Novel monoclonal antibodies for the investigation of PCH family proteins.
Signal Transduction 7:320-328, 2007
Lettau M, Schmidt H, Kabelitz D, Janssen O.
Secretory lysosomes and their cargo in T and NK cells.
Immunol Lett 108: 10-19, 2007
Möhlig H, Mathieu S, Thon L, Frederikdsen MC, Ward DM, Kaplan J, Schütze S, Kabelitz D, Adam D.
The WD repeat protein FAN regulates lysosome size independent from abnormal downregulation/membrane recruitment of protein kinase C.
Exp Cell Res 313: 2703-2718, 2007
Schulte M*, Reiss K*, Lettau M*, Maretzky T, Ludwig A, Hartmann D, de Strooper B, Janssen O*, Saftig P*.
ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death.
Cell Death Differ 14:1040-1049, 2007
*equally contributing first and last authors
Weichenthal M, Ruether A, Schreiber S, Nair R, Voorhees JJ, Schwarz T, Kabelitz D, Christophers E, Elder JT, Jenisch S.
Filaggrin R501X and 2282del4 mutations are not associated with chronic plaque-type psoriasis in a German cohort.
J Invest Dermatol 127: 1535 - 1537, 2007
Wesch D, Marischen L, Kabelitz D.
Expression von Chemokinrezeptoren. In: Zelluläre Diagnostik. Grundlagen, Methoden und klinische Anwendungen der Durchflusszytometrie. Sack U, Tarnok A, Rothe G (Hrsg.)
Karger Publishers, Basel, 424-436, 2007
Wrobel P, Shojaei H, Schittek B, Gieseler F, Wollenberg B, Kalthoff, H, Kabelitz D, Wesch D
Lysis of broad range of epithelial tumour cells by human gamma/delta-T cells: involvement of NKG2D ligands and T cell receptor - versus NKG2D-dependent recognition.
Scand J Immunol 66: 320-328, 2007
